Magnus Grönberg, Author at Inify Laboratories

Inify Laboratories – Årsredovisning 2022

Årsredovisningar, Finansiella rapporter, Swedish news 2023-04-12

Stockholm – 12 April, 2023 – Inify Laboratories, ett företag som tillhandahåller helt digitaliserade laboratorietjänster inom prostatacancerdiagnostik, presenterar sin årsredovisning för räkenskapsåret som avslutades den 31 december 2022. Årsredovisningen bifogas […]

Panel talk about Inify’s fourth quarter 2022

Investor News 2023-02-23

During the last quarter of 2022, Inify Laboratories moved into its brand-new premises at Campus Solna just outside of Stockholm. The laboratory was finished in record time and all essential […]

Inify Laboratories – Ultramodern AI-based digital pathology laboratory completed in record time

Financial reports, Investor News 2023-02-22

STOCKHOLM – February 22, 2023 – Inify Laboratories, a company providing fully digitalized laboratory services within prostate cancer diagnostics, has completed its new laboratory – including staffing up with skilled […]

Panel talk about Inify’s third quarter

Investor News 2022-11-09

The third quarter of 2022 saw progress in several areas, such as the construction of the laboratory facilities in Campus Solna in Stockholm, the setup of a simulation laboratory in Linköping […]

Inify Laboratories – Laboratory and recruitment on track with positive market feedback

Financial reports, Investor News 2022-10-26

STOCKHOLM – October 26, 2022 Inify Laboratories, a fully integrated digital ultramodern laboratory services within pathology that provides cancer diagnostics, is advancing towards opening of the company’s new laboratory, situated […]

Inify Laboratories AB (publ) – Extra bolagsstämma

Swedish news 2022-08-30

Stockholm, Sverige, 30 augusti, 2022; Idag den 30 augusti 2022, höll Inify Laboratories AB, org. nr. 559345-4431, en extra bolagsstämma i Stockholm. Totalt var 31 807 064 aktier representerade på […]

Inify Laboratories AB (publ) – Extraordinary General Meeting

Annual General Meeting, Investor News 2022-08-30

Stockholm, Sweden, August 30, 2022; Today, the 30th of August 2022, Inify Laboratories AB, org. no. 559345-4431, held an extraordinary general meeting in Stockholm. Total 31,807,064 shares were represented at […]

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2022-08-19

Stockholm, Sweden, August 19, 2022 – Inify Laboratories AB (“Inify”) has been notified that the following transaction has been completed by a close associate to a primary insider in Inify: […]

Inify’s first ultramodern laboratory on track

Finansiella rapporter, Swedish news 2022-08-17

STOCKHOLM – August 17 2022 – Inify Laboratories, a company providing fully digitalized pathology laboratory services for cancer diagnostics, listed in June 2022 on the Euronext Growth in Oslo, is […]

Inify’s first ultramodern laboratory on track

Financial reports, Investor News, News 2022-08-17

Inify Laboratories – Årsredovisning 2022

Panel talk about Inify’s fourth quarter 2022

Inify Laboratories – Ultramodern AI-based digital pathology laboratory completed in record time

Panel talk about Inify’s third quarter

Inify Laboratories – Laboratory and recruitment on track with positive market feedback

Inify Laboratories AB (publ) – Extra bolagsstämma

Inify Laboratories AB (publ) – Extraordinary General Meeting

Inify Laboratories – mandatory notification of trade

Inify’s first ultramodern laboratory on track

Inify’s first ultramodern laboratory on track

Our services

Inify Laboratories

For Investors

Contact us

Social media